Back to the main directory
Press Release
- Braze Announces Support for AWS for Advertising & Marketing Initiative by BusinessWire
- ROHM Develops Ultra-Low-Power, On-Device Learning Edge AI Chip by GlobeNewsWire
- Yooma Wellness Reports Results for Third Quarter of 2022 by GlobeNewsWire
- nCino Appoints New Board Member by GlobeNewsWire
- MDxHealth fait le point sur ses activités by GlobeNewsWire
- Semantix Announces 3Q 2022 Financial Results by GlobeNewsWire
- Karolinska Developments portföljbolag OssDsign har genomfört en riktad nyemission om cirka 65,6 miljoner kronor by GlobeNewsWire
- Lee Enterprises plans quarterly call and webcast December 8, 2022 by GlobeNewsWire
- AbraSilver Announces $8 Million "Bought Deal" Private Placement by GlobeNewsWire
- Berry Corporation Announces Management Succession Plan, Reinforces Focus on Shareholder Return Maximization by GlobeNewsWire
- NXP Foundation Commits $250,000 to Advance Engineering Education at Austin Community College District by GlobeNewsWire
- Greenbriar Comprehensive News Release and Q3 2022 Financials by Newsfile Corp.
- Alcon Prices US$1.3 Billion Senior Notes Offering by BusinessWire
- Reliq Health Technologies, Inc. Files Q1 FY 2023 Financial Statements, Announces Record Growth by GlobeNewsWire
- EQS-News: YOC AG: YOC lanciert NOMI®, eine algorithmische Intelligenz, die High-Impact-Advertising auf das nächste Level bringt by EQS Group AG
- Advicenne annonce son calendrier financier 2023 by BusinessWire
- Flex LNG - Ex Date Q3 2022 by GlobeNewsWire
- Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten by GlobeNewsWire
- RESULTATS S1 2022-23 : PROGRESSION DE 18.8% DU REX (+2.4 M€ VS +2 M€ SUR LE S1 2021-22), ET DE 14.1% DE L’EBITDA (+2.5 M€ VS +2.2 M€) MALGRE UN EFFET DE BASE ELEVE. RESULTAT NET : +1.2 M€ VS +1.9M€ LIE A UN EFFET DE CHANGE DE -856 K€. PERSP by GlobeNewsWire
- Rand Merchant Bank (RMB): IHS Holding Limited completes $600 Million Three-Year Bullet-Term Loan by EQS Group AG
- BioNTech und Ryvu Therapeutics schließen globale Kollaboration zur Entwicklung und Vermarktung von immunmodulierenden niedermolekularen Wirkstoffen by GlobeNewsWire
- Sensorion receives Orphan Drug Designation for OTOF-GT for the treatment of otoferlin gene-mediated hearing loss from the US Food and Drug Administration by BusinessWire
- BGHL (EUR): NAV(s) by GlobeNewsWire
- Sampo plc’s share buybacks 29/11/2022 by GlobeNewsWire
- Azerion publishes Interim Unaudited Q3 2022 Results by GlobeNewsWire